Logo image of ALCE

ALTERNUS CLEAN ENERGY INC (ALCE) Stock Fundamental Analysis

NASDAQ:ALCE - Nasdaq - US02157G2003 - Common Stock - Currency: USD

0.226  -0.06 (-20.65%)

After market: 0.17 -0.06 (-24.78%)

Fundamental Rating

0

ALCE gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 19 industry peers in the Independent Power and Renewable Electricity Producers industry. ALCE may be in some trouble as it scores bad on both profitability and health. ALCE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCE has reported negative net income.
In the past year ALCE had a positive cash flow from operations.
ALCE Yearly Net Income VS EBIT VS OCF VS FCFALCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -102.44%, ALCE is doing worse than 89.47% of the companies in the same industry.
Industry RankSector Rank
ROA -102.44%
ROE N/A
ROIC N/A
ROA(3y)-12.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCE Yearly ROA, ROE, ROICALCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 50 100

1.3 Margins

The Gross Margin of ALCE (76.17%) is better than 78.95% of its industry peers.
The Profit Margin and Operating Margin are not available for ALCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCE Yearly Profit, Operating, Gross MarginsALCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

ALCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALCE has less shares outstanding than it did 1 year ago.
The debt/assets ratio for ALCE is higher compared to a year ago.
ALCE Yearly Shares OutstandingALCE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
ALCE Yearly Total Debt VS Total AssetsALCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -3.26, we must say that ALCE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALCE (-3.26) is worse than 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.26
ROIC/WACCN/A
WACC4.11%
ALCE Yearly LT Debt VS Equity VS FCFALCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.34 indicates that ALCE may have some problems paying its short term obligations.
ALCE's Current ratio of 0.34 is on the low side compared to the rest of the industry. ALCE is outperformed by 89.47% of its industry peers.
ALCE has a Quick Ratio of 0.34. This is a bad value and indicates that ALCE is not financially healthy enough and could expect problems in meeting its short term obligations.
ALCE has a worse Quick ratio (0.34) than 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
ALCE Yearly Current Assets VS Current LiabilitesALCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALCE have decreased strongly by -22771.43% in the last year.
EPS 1Y (TTM)-22771.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCE Yearly Revenue VS EstimatesALCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCE Price Earnings VS Forward Price EarningsALCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCE Per share dataALCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTERNUS CLEAN ENERGY INC

NASDAQ:ALCE (2/11/2025, 8:05:01 PM)

After market: 0.17 -0.06 (-24.78%)

0.226

-0.06 (-20.65%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.16%
Inst Owner Change-46.07%
Ins Owners0.24%
Ins Owner Change32.61%
Market Cap1.33M
AnalystsN/A
Price TargetN/A
Short Float %0.41%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 0.25
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-31.74
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.23
FCFYN/A
OCF(TTM)0.91
OCFY404.45%
SpS3.82
BVpS-14.01
TBVpS-15.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.17%
FCFM N/A
ROA(3y)-12.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -3.26
F-Score4
WACC4.11%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22771.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-935.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y357.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3403%
OCF growth 3YN/A
OCF growth 5YN/A